Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The ...
We recently published 11 Stocks Jim Cramer Shared His Insights On. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed. Eli Lilly and Company (NYSE:LLY) is one of Cramer’s top ...
Eli Lilly (LLY) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American stock to currently cross the landmark threshold. The move came as ...
Fintel reports that on November 12, 2025, Citigroup maintained coverage of Eli Lilly and (NYSE:LLY) with a Buy recommendation. Analyst Price Forecast Suggests 8.95% Downside As of November 9, 2025, ...
Hosted on MSN
Leerink Partners Upgrades Eli Lilly and (LLY)
Fintel reports that on November 10, 2025, Leerink Partners upgraded their outlook for Eli Lilly and (NYSE:LLY) from Market Perform to Outperform. Analyst Price Forecast Suggests 0.26% Upside As of ...
Eli Lilly's Mounjaro and Zepbound deliver accelerated weight loss rates compared to Novo Nordisk's Wegovy, which perhaps explains the former's triple-digit GLP-1 revenue growth on a YoY basis. This is ...
Eli Lilly and Company (NYSE:LLY) is included among the 10 Best Rising Dividend Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) is seen as a strong healthcare stock that investors can ...
Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...
On this episode of Stock Movers: - Nvidia (NVDA) is lower after China’s internet watchdog has instructed companies including Alibaba and ByteDance to terminate orders for Nvidia’s RTX Pro 6000D, the ...
An EGR delete is seen by many as an easy way to improve performance and efficiency by removing the EGR (exhaust gas recirculation), which is a component that helps in reducing the NOx that is thrown ...
The move prompted Chief Market Strategist Shay Boloor of Futurum Equities to declare that a company like Lilly “doesn’t issue a 40-year bond unless they’re setting up for something BIG.” The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback